QuantuMDx Group today announces the launch of its sensitive SARS-CoV-2 assay for laboratory use, which delivers a result in approximately 70 minutes. Working with British manufacturing partner Biofortuna Limited, QuantuMDx
QuantuMDx today announces a business update and the appointments of Jonathan O’Halloran as Chief Executive Officer and Neil Butler as Chairman of the Board, as the company begins its transition
Isbelis Lopez is a KTP Associate at QuantuMDx. Here, she tells us more about her role. When did you know you wanted to be a scientist and why? Growing up
Improving outcomes for sepsis patients and promoting antibiotic stewardship QuantuMDx and Ontera, have announced a collaboration to create a next-generation solution for blood stream infection and drug resistance detection. The
Investigating feasibility of rapid, low-cost STI diagnostics development QuantuMDx and SpeeDx today announced a collaboration with the Foundation for Innovative New Diagnostics (FIND). The global non-profit organization drives development and
What is Antimicrobial Resistance? One of the biggest misconceptions is that we’re becoming resistant to antibiotics. In fact, it’s bacteria that are becoming resistant to antibiotics. Antimicrobial Resistance (AMR) develops
QuantuMDx has announced that Neil Butler has joined its Board as an Independent Non-Executive Director. Neil is a seasoned healthcare executive with over 20 years’ experience working in, and managing,
Paul Steele, Senior QA/RA Officer, gives us an insight into his role. When did you know you wanted to work in Quality Assurance and why? It was probably back when I
This month Heather Murton, Head of Clinical Assay, is giving us the lowdown on her role. When did you know you wanted to be a scientist and why? By
QuantuMDx Group Ltd has announced plans to expand the potential of its Q-POC™ technology and develop a quality control analytics system for cell and gene therapies (C>s), to be evaluated
